Capillary lesions develop in retina rather than cerebral cortex in diabetes and experimental galactosemia

Archives of Ophthalmology

Volumn 114, Issue 3, 1996, Pages 306-310

  Kern, Timothy S ^a,b   Engerman, Ronald L ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; BRAIN CAPILLARY; BRAIN CORTEX; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; DOG; GALACTOSEMIA; HYPERGLYCEMIA; MICROANEURYSM; MICROANGIOPATHY; MICROVASCULATURE; NONHUMAN; PERICYTE; PRIORITY JOURNAL; RETINA; RETINOPATHY;

EID: 0029915447     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.1996.01100130302013     Document Type: Article

References (30)

1. Engerman RL, Kern TS. Experimental galactosemia produces diabeticlike retinopathy Diabetes. 1984;33:97-100.
2. Kuwabara T, Cogan DG. Retinal vascular patterns, VI: mural cells of retinal capillaries. Arch Ophthalmol. 1963:69 492-502.
3. de Oliveira F. Pericytes in diabetic retinopathy Br J Ophthalmol 1966;50:134-143.
4. Addison DJ, Garner A, Ashton N. Degeneration of intramural pericytes in diabetic retinopathy. BMJ. 1970;1:264-266.
5. Frank RN, Dutta S, Frank SE Cerebral cortical capillary basement membrane thickening in galactosemic rats. Diabetologia. 1987;30.739-744.
6. Engerman RL, Kern TS. Progression of incipient diabetic retinopathy during good glycemic control. Diabetes. 1987,36 808-812
7. Engerman RL, Kern TS. Aldose reductase inhibition fails to prevent retinopathy in diabetic and galactosemic dogs. Diabetes. 1993;42:820-825.
8. Engerman RL, Kern TS, Garment MB. Capillary basement membrane in retina, kidney, and muscle of diabetic dogs and galactosemic dogs and its response to 5 years aldose reductase inhibition. J Diabetes Complications. 1993,7:241-245.
9. Meezan E, Brendel K, Carlson C. Isolation of a purified preparation of metabolically active retinal blood vessels Nature. 1974;251:65-67
10. Kern TS, Engerman RL Hexitol production by canine microvessels. Invest Ophthalmol Vis Sci. 1985;26:382-384.
11. Siperstein M, Unger R, Madison L Studies of muscle capillary basement membrane in normal subjects, diabetic, and prediabetic patients J Clin Invest. 1968; 47:1973-1999.
12. Williamson JR, Vogler NJ, Kilo C. Estimation of vascular basement membrane thickness. Diabetes 1969,18:567-578.
13. Johnson PC, Brendel K, Meezan E Thickened cerebral cortical capillary basement membranes in diabetes. Arch Pathol Lab Med. 1982;106:214-217.
14. Mukai N, Hori S, Pomeroy S Cerebral lesions in rats with streptozotocin-induced diabetes. Acta Neuropathol (Berl). 1980;51 79-84.
15. Fang CH The studies of cerebral arterioles and capillaries in normal and pathologic states in man. In: Cervos-Navarro J, ed. Pathology of Cerebral Microcirculation Berlin, Germany. Walter de Gruyter & Co; 1974:431-441.
16. Reske-Nielsen E, Lundbaek K, Rafaelsen OJ. Pathological changes in the central and peripheral nervous system of young long-term diabetics, I: diabetic encephalopathy. Diabetologia. 1965;1:233-241.
17. Jakobsen J, Sidenius P, Gundersen HJG, Osterby R. Quantitative changes of cerebral neocortical structure in insulin-treated long-term streptozocin-induced diabetes in rats. Diabetes. 1987;36:597-601.
18. Osterby Hansen R, Lundbaek K: The basement membrane morphology in diabetes mellitus In: Ellenberg M, Rifkin H, eds. Diabetes Mellitus: Theory and Practice New York, NY: McGraw-Hill International Book Co; 1970 178-209.
19. Engerman RL, Colquhoun PJ Jr Epithelial and mesothelial basement membranes in diabetic patients and dogs Diabetologia. 1982,23:521-524.
20. Frank RN, Dutta S, Mancini MA. Pericyte coverage is greater in the retinal than in the cerebral capillaries of the rat. Invest Ophthalmol Vis Sci. 1987;28:1086-1091
21. Frank RN, Turczyn TJ, Das A Pericyte coverage of retinal and cerebral capillaries. Invest Ophthalmol Vis Sci. 1990,31 999-1007
22. Belloni-Olivi L, Bressler JP, Goldstein GW Retinal microvessels express less gamma-glutamyl transpeptidase than brain microvessels Curr Eye Res. 1992, 11:203-211.
23. Kowluru R, Kern TS, Engerman RL. Abnormalities of retinal metabolism in diabetes or galactosemia, II. comparison of γ-glutamyl transpeptidase in retina and cerebral cortex, and effects of antioxidant therapy. Curr Eye Res 1994, 13:891-896.
24. Wong Y-HH, Kalmbach SJ, Hartman BK, Sherman WR. Immunohistochemical staining and enzymatic activity measurements show myo-inositol-1-phosphate synthase to be localized in the vasculature of brain. J Neurochem. 1987;48:1434-1442.
25. Tilton RG, LaRose LS, Sherman WR. Myo-inositol-1-phosphate synthase is localized to vascular pericytes in brain and optic nerve but not in retina. Invest Ophthalmol Vis Sci. 1989,30(suppl) 212. ARVO abstract.
26. Kennedy A, Frank RN, Varma SD Aldose reductase activity in retinal and cerebral microvessels and cultured vascular cells Invest Ophthalmol Vis Sci 1983, 24:1250-1258.
27. Shiba T, Inoguchi T, Sportsman JR, et al Correlation of diacylglycerol and protein kinase C in rat retina to retinal circulation Am J Physiol 1993;265. 783-793.
28. 125I-albumin permeation in galactose-fed rats: inhibition with sorbinil. Invest Ophthalmol Vis Sci 1988;29:861-868
29. Nishimura C, Kuriyama K Alteration of lipid peroxide and endogenous antioxidant contents in retina of streptozotocin-induced diabetic rats; effect of vitamin A administration Jpn J Pharmacol. 1985;37 365-372
30. Kern TS, Engerman RL. Vascular lesions in diabetes are distributed non-uniformly within the retina. Exp Eye Res. 1995;60:545-549.